JPH0710883A - Production of gamma-lactam derivative - Google Patents

Production of gamma-lactam derivative

Info

Publication number
JPH0710883A
JPH0710883A JP5195066A JP19506693A JPH0710883A JP H0710883 A JPH0710883 A JP H0710883A JP 5195066 A JP5195066 A JP 5195066A JP 19506693 A JP19506693 A JP 19506693A JP H0710883 A JPH0710883 A JP H0710883A
Authority
JP
Japan
Prior art keywords
formula
carboxylic acid
group
lactam
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5195066A
Other languages
Japanese (ja)
Inventor
Masaji Ishiguro
正路 石黒
Takashi Nakatsuka
隆 中塚
Rie Tanaka
里枝 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Priority to JP5195066A priority Critical patent/JPH0710883A/en
Publication of JPH0710883A publication Critical patent/JPH0710883A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PURPOSE:To carry out the ring enlarging reaction of the beta-lactam ring and simply and readily obtain the subject compound useful as an antimicrobial agent or its synthetic raw material by removing a carboxylic acid-protecting group in a specific beta-lactam derivative. CONSTITUTION:A carboxylic acid-protecting group R<1> of a beta-lactam derivative expressed by formula I [R<1> and R<2> are protecting group of carboxylic acid; the dotted line indicates the presence or absence) of bond; when the bond is absent, R<3> and R<4> are methyl and when the bond is present, R<3> is tetrahydrofuryl or tetrahydrofurylmethyl and R<4> is absent] to afford the objective compound expressed by formula II. Specifically, e.g. when R<1> is trichloroethvl, zinc dust is reacted therewith in a solvent such as THF. Furthermore, the compound expressed by formula I is obtained by using, e.g. (1'R,2'R,3S,4R)3-(1'-tert- butyldimethylsilyloxyethyl)-4-(2'-tetrahydrofurylca.rbonylthio)azetidi none expressed by formula III as a starting raw material.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、β−ラクタム環の環拡
大反応によって得られる新規なγ−ラクタム誘導体の製
造法に関する。
TECHNICAL FIELD The present invention relates to a method for producing a novel γ-lactam derivative obtained by a ring expansion reaction of a β-lactam ring.

【0002】[0002]

【従来の技術】現在、β−ラクタム化合物は抗菌剤とし
て非常に重要な化合物であるが、耐性菌が出現してきて
いる。そのため、この耐性菌に有効な抗菌剤を得るため
にβ−ラクタム化合物からの様々な展開がなされている
が、その中でもβ−ラクタム化合物の類似構造化合物と
してγ−ラクタム化合物が注目されており、合成と抗菌
活性の評価が行われて、抗菌活性を示すものが報告され
ている(Tetrahedron,45(1989)
p.4537−4550)。また、γ−ラクタム化合物
の合成法としては、J.Chem.Soc.Chem.
Commun.,(1988)p.110−111等に
例示されるようにβ−ラクタム化合物から環拡大によっ
て得る方法、あるいは、J.Chem.Soc.,Pe
rkin Trans.,(1986)p.2195
−2198等に例示されるようなアゼチジノンの3位に
アジド基を持つ化合物の転移反応を利用する方法等が知
られている。その他の合成法は、例えば、The Jo
urnal of Antibiotics,44
〔1〕(1991)p.1−24に例示されている。し
かしながら、従来のγ−ラクタム化合物の合成法は複雑
であり、また得られるγ−ラクタム化合物の種類も少な
く、十分な抗菌活性を持つγ−ラクタム化合物は未だ見
い出されていない。一方、Sheehanらは、ペナム
環の6位のカルボン酸の保護基がベンジル基、2位のカ
ルボン酸の保護基がトリクロロエチル基、及び3位にジ
メチル基を有する化合物をPd/C触媒下水素化分解す
ることによって、6位のカルボン酸の脱保護を行い、β
−ラクタム化合物を与えることを報告している(J.O
rg.Chem.,42〔25〕(1977)p.40
45−4048)が、それがγ−ラクタム化合物へ分解
することは報告していない。かかる状況下、簡便なγ−
ラクタム化合物の合成法の提供が切望されていた。
2. Description of the Related Art Currently, β-lactam compounds are used as antibacterial agents.
It is a very important compound, but the emergence of resistant bacteria
There is. Therefore, in order to obtain an effective antibacterial agent against this resistant bacterium
Various developments have been made from β-lactam compounds
However, among them, similar structure compounds of β-lactam compound
Since then, γ-lactam compounds have been attracting attention, and their synthesis and antibacterial
The activity was evaluated and those showing antibacterial activity were reported.
(Tetrahedron,45(1989)
p. 4537-4550). In addition, a γ-lactam compound
The synthetic method of J. Chem. Soc. Chem.
Commun. , (1988) p. 110-111 etc.
As illustrated, by ring expansion from a β-lactam compound.
Method, or J. Chem. Soc. , Pe
rkin Trans. ,I(1986) p. 2195
-At the 3rd position of azetidinone as illustrated in 2198 etc.
Methods such as utilizing the transfer reaction of compounds with azido groups are known.
Has been. Other synthetic methods include, for example, The Jo
urn of of Antibiotics,44
[1] (1991) p. 1-24. Shi
However, conventional methods for synthesizing γ-lactam compounds are complicated.
And the number of γ-lactam compounds obtained is small.
Γ-lactam compounds with sufficient antibacterial activity have not yet been found.
It has not been served. Meanwhile, Sheehan et al.
The protecting group for the carboxylic acid at the 6-position of the ring is a benzyl group and the protecting group at the 2-position is
The protecting group for rubonic acid is a trichloroethyl group, and a di-
Hydrogenolysis of a compound having a methyl group under Pd / C catalyst
By deprotecting the carboxylic acid at the 6-position, β
-Reporting to give lactam compounds (JO
rg. Chem. ,42[25] (1977) p. 40
45-4048), which decomposes into a γ-lactam compound
I have not reported anything to do. Under such circumstances, a simple γ-
It has been earnestly desired to provide a synthetic method for lactam compounds.

【0003】[0003]

【発明が解決しようとする課題】本発明は、抗菌剤ある
いはその合成原料として有用なγ−ラクタム誘導体の簡
便容易な製造法を提供するものである。
The present invention provides a simple and easy method for producing a γ-lactam derivative useful as an antibacterial agent or a raw material for its synthesis.

【0004】[0004]

【課題を解決するための手段】本発明は、式(I):The present invention provides the formula (I):

【化3】 (式中、R及びRは、同一または異なるカルボン酸
の保護基を示し、点線は結合の存在または不存在を示
し、結合が存在しない場合には、R及びRはメチル
基を示し、結合が存在する場合には、Rはテトラヒド
ロフリル基またはテトラヒドロフリルメチル基を示し、
は存在しない)で表される化合物のカルボン酸の保
護基Rを除去することにより、β−ラクタム環の分解
を伴って得られる式(II):
[Chemical 3] (In the formula, R 1 and R 2 represent the same or different carboxylic acid protecting groups, the dotted line indicates the presence or absence of a bond, and when the bond does not exist, R 3 and R 4 represent a methyl group. And when a bond is present, R 3 represents a tetrahydrofuryl group or a tetrahydrofurylmethyl group,
R 4 is absent) by removing the protecting group R 1 of the carboxylic acid of the compound represented by formula (II) obtained with the decomposition of the β-lactam ring:

【化4】 (式中、R、R、R及び点線は前記した意味を有
する)で表されるγ−ラクタム誘導体の製造法である。
[Chemical 4] (In the formula, R 2 , R 3 , R 4 and the dotted line have the meanings described above).

【0005】式(II)で表されるγ−ラクタム誘導体
は、カルボン酸の保護基Rを除去することによって式
(III):
The γ-lactam derivative represented by the formula (II) has the formula (III): by removing the protecting group R 2 of the carboxylic acid.

【化5】 (式中、R、R及び点線は前記した意味を有し、Z
は水素原子またはナトリウム、カリウム等のアルカリ金
属を示す)で表されるγ−ラクタム誘導体に変換するこ
とができる。
[Chemical 5] (Wherein R 3 , R 4 and the dotted line have the above-mentioned meanings, Z
Represents a hydrogen atom or an alkali metal such as sodium or potassium) and can be converted into a γ-lactam derivative.

【0006】また、式(II)で表されるγ−ラクタム
誘導体は、式(IV):
The γ-lactam derivative represented by the formula (II) has the formula (IV):

【化6】 (式中、Rは水素原子、フリルメチル基またはベンジ
ル基を示す)で表されるアミンを反応させることによっ
て式(V):
[Chemical 6] (In the formula, R 5 represents a hydrogen atom, a furylmethyl group or a benzyl group) to react with an amine represented by the formula (V):

【化7】 (式中、R、R、R、R及び点線は前記した意
味を有する)で表されるγ−ラクタム誘導体に変換する
ことができ、さらに、式(V)で表されるγ−ラクタム
誘導体は、カルボンの保護基Rを除去することによっ
て式(VI):
[Chemical 7] (Wherein R 2 , R 3 , R 4 , R 5 and the dotted line have the above-mentioned meanings), and a γ-lactam derivative represented by the formula (V) can be obtained. - lactam derivatives of the formula by removing the protecting group R 2 in the carboxylic (VI):

【化8】 (式中、R、R、R、Z及び点線は前記した意味
を有する)で表されるγ−ラクタム誘導体に変換するこ
とができる。
[Chemical 8] (In the formula, R 3 , R 4 , R 5 , Z and the dotted line have the above-mentioned meanings), and can be converted into a γ-lactam derivative.

【0007】本発明のγ−ラクタム誘導体において、R
は、γ−ラクタム環、R、R及びRに対して影
響を及ぼさないカルボン酸の保護基であれば何でもよい
が、例えばアリル基、トリクロロエチル基、メチル基、
ベンジル基、tert−ブチル基等を挙げることができ
る。Rで示されるカルボン酸の保護基は、目的とする
化合物が式(III)で表されるγ−ラクタム誘導体で
ある場合には、Rと同一の条件で除去できるものでよ
く、例えばアリル基、トリクロロエチル基、メチル基、
ベンジル基、tert−ブチル基等を挙げることができ
るが、目的とする化合物が式(II)で表されるγ−ラ
クタム誘導体である場合には、Rの除去条件では影響
を受けない保護基である必要がある。例えば、Rで示
されるカルボン酸の保護基がトリクロロエチル基である
場合には、ベンジル基、アリル基等が、またR示され
るカルボン酸の保護基がメチル基の場合には、ベンジル
基等が好ましい。
In the γ-lactam derivative of the present invention, R
1 may be any carboxylic acid protecting group that does not affect the γ-lactam ring, R 2 , R 3 and R 4 , and examples thereof include an allyl group, a trichloroethyl group, a methyl group,
Examples thereof include a benzyl group and a tert-butyl group. Protecting group of a carboxylic acid represented by R 2, when the compound of interest is a γ- lactam derivative represented by the formula (III) may be those which can be removed under the same conditions as R 1, such as allyl Group, trichloroethyl group, methyl group,
Examples thereof include a benzyl group and a tert-butyl group, but when the target compound is a γ-lactam derivative represented by the formula (II), a protecting group that is not affected by the removal conditions of R 1 Must be For example, when the carboxylic acid protecting group represented by R 1 is a trichloroethyl group, a benzyl group, an allyl group, or the like, and when the carboxylic acid protecting group represented by R 1 is a methyl group, a benzyl group Etc. are preferred.

【0008】式(I)で表されるβ−ラクタム誘導体を
式(II)で表されるγ−ラクタム誘導体に変換する反
応は、公知のカルボン酸の脱保護法により行うことがで
き、特に限定されず、出発原料であるβ−ラクタム誘導
体の種類により反応試薬を適宜選択し、行えばよい。反
応試薬としては例えばRで示されるカルボン酸の保護
基がトリクロロエチル基の場合には、亜鉛末、メチル基
またはベンジル基の場合には、ヨードトリメチルシラ
ン、アリル基の場合には、テトラキストリフェニルフォ
スフィンパラジウム等のパラジウム触媒と2−エチルヘ
キサン酸またはその塩等のアリル基受容体によるエステ
ル交換反応、またtert−ブチル基の場合には、トリ
フルオロ酢酸等を用いることができる。反応に用いる溶
媒はβ−ラクタム誘導体の種類及び用いる試薬により、
適宜選択すればよく、例えば、ベンゼン、トルエン等の
炭化水素、ジクロロメタン、クロロホルム等のハロゲン
化炭化水素、テトラヒドロフラン、ジエチルエーテル等
のエーテル類、酢酸エチル、ジメチルホルムアミド、ジ
メチルスルホキシド、水またはこれらの混合物が例示さ
れ、また試薬の用量は、反応の種類により適宜選択で
き、5モル%から大過剰用いる。反応温度は、式(I)
で表される化合物のカルボン酸の保護基の種類により異
なるが、通常0℃〜50℃の範囲で、好ましくは、0℃
〜室温である。
The reaction for converting the β-lactam derivative represented by the formula (I) into the γ-lactam derivative represented by the formula (II) can be carried out by a known deprotection method of carboxylic acid, and is particularly limited. Instead, the reaction reagent may be appropriately selected and performed depending on the type of the β-lactam derivative that is the starting material. Examples of the reaction reagent include zinc dust when the carboxylic acid protecting group represented by R 1 is a trichloroethyl group, iodotrimethylsilane when it is a methyl group or a benzyl group, and tetrakistris when it is an allyl group. A transesterification reaction using a palladium catalyst such as phenylphosphine palladium and an allyl group acceptor such as 2-ethylhexanoic acid or a salt thereof, or trifluoroacetic acid in the case of a tert-butyl group can be used. The solvent used in the reaction depends on the type of β-lactam derivative and the reagent used,
It may be appropriately selected, for example, hydrocarbons such as benzene and toluene, halogenated hydrocarbons such as dichloromethane and chloroform, ethers such as tetrahydrofuran and diethyl ether, ethyl acetate, dimethylformamide, dimethylsulfoxide, water or a mixture thereof. The dose of the reagent is exemplified and can be appropriately selected depending on the type of reaction, and is used in a large excess from 5 mol%. The reaction temperature is represented by the formula (I)
It depends on the kind of the protecting group of the carboxylic acid of the compound represented by
~ Room temperature.

【0009】式(II)で表されるγ−ラクタム誘導体
は、ベンゼン、トルエン等の炭化水素、ジクロロメタ
ン、クロロホルム等のハロゲン化炭化水素、テトラヒド
ロフラン、ジエチルエーテル等のエーテル類、酢酸エチ
ル、ジメチルホルムアミド、ジメチルスルホキシド、水
またはこれらの混合物等の溶媒中、塩基の存在下、式
(IV)で表されるアミンを反応させることによって、
式(V)で表されるγ−ラクタム誘導体に変換すること
ができる。本反応で用いられる塩基としては、ピリジ
ン、ジメチルアミノピリジン、トリエチルアミン等が挙
げられ、縮合剤としてブロモトリスピロリジノフォスフ
ォニウムヘキサフルオロフォスフェート、N,N’−ジ
シクロヘキシルカルボジイミド(DCC)、N−エチル
−N’−ジエチルアミノエチルカルボジイミド、N−エ
チル−N’−ジメチルアミノプロピルカルボジイミドま
たはベンゾトリアゾール−1−イルオキシ−トリス(ジ
メチルアミノ)フォスフォニウムヘキサフルオロフォス
フェート(BOP)またはその酸付加塩等が例示され
る。反応には、γ−ラクタム誘導体(II)に対し、通
常は、アミン(IV)を100〜150モル%、縮合剤
を100〜150モル%用い、塩基は用いる縮合剤によ
りその用量及び種類を適宜選択して通常、0〜150モ
ル%用いる。反応温度は、通常−20℃〜50℃の範囲
で、好ましくは、0℃〜室温である。
The γ-lactam derivative represented by the formula (II) includes hydrocarbons such as benzene and toluene, halogenated hydrocarbons such as dichloromethane and chloroform, ethers such as tetrahydrofuran and diethyl ether, ethyl acetate and dimethylformamide, By reacting an amine represented by the formula (IV) in the presence of a base in a solvent such as dimethyl sulfoxide, water or a mixture thereof,
It can be converted into a γ-lactam derivative represented by the formula (V). Examples of the base used in this reaction include pyridine, dimethylaminopyridine, triethylamine and the like, and as a condensing agent, bromotris-pyrrolidinophosphonium hexafluorophosphate, N, N′-dicyclohexylcarbodiimide (DCC), N-ethyl. Examples include -N'-diethylaminoethylcarbodiimide, N-ethyl-N'-dimethylaminopropylcarbodiimide, benzotriazol-1-yloxy-tris (dimethylamino) phosphonium hexafluorophosphate (BOP) and acid addition salts thereof. To be done. In the reaction, usually 100 to 150 mol% of the amine (IV) and 100 to 150 mol% of the condensing agent are used with respect to the γ-lactam derivative (II), and the base is appropriately selected in dose and kind depending on the condensing agent used. It is usually selected and used in an amount of 0 to 150 mol%. The reaction temperature is generally in the range of -20 ° C to 50 ° C, preferably 0 ° C to room temperature.

【0010】式(II)及び(V)で表されるγ−ラク
タム誘導体は、それぞれ、カルボン酸の脱保護により式
(III)及び(VI)で表されるγ−ラクタム誘導体
に変換することができる。また、脱保護法は公知の方法
により行うことができるが、例えば先に述べた式(I)
で表されるβ−ラクタム誘導体を式(II)で表される
γ−ラクタム誘導体に変換する反応において例示した方
法で行うことができる。
The γ-lactam derivatives represented by the formulas (II) and (V) can be converted into the γ-lactam derivatives represented by the formulas (III) and (VI) by deprotection of the carboxylic acid, respectively. it can. The deprotection method can be carried out by a known method, for example, the above-mentioned formula (I)
The β-lactam derivative represented by the formula (II) can be converted into the γ-lactam derivative represented by the formula (II) by the method exemplified in the reaction.

【0011】[0011]

【実施例】以下に実施例により本発明をさらに詳細に説
明するが、本発明はこの実施例に限定されるものではな
い。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

【0012】参考例1 (2’R,4R)−3−エチリデン−4−(2’−テト
ラヒドロフリルカルボニルチオ)−1−tert−ブチ
ルジメチルシリルアゼチジノン(2)の合成:
Reference Example 1 Synthesis of (2'R, 4R) -3-ethylidene-4- (2'-tetrahydrofurylcarbonylthio) -1-tert-butyldimethylsilylazetidinone (2):

【化9】 (1’R,2’R,3S,4R)−3−(1’−ter
t−ブチルジメチルシリルオキシエチル)−4−(2’
−テトラヒドロフリルカルボニルチオ)アゼチジノン
(1)70.0gのメタノール溶液に氷冷下、4N H
Cl/ジオキサン溶液 160mlを加え、2.5時間
撹拌した。この溶液をNaHCO(50g)の水溶液
(500ml)にあけ、酢酸エチルで抽出した。無水M
gSO乾燥後、溶媒を留去し、目的物を含む残渣 4
0.1gを得た。これを 320mlの塩化メチレンに
溶解し、tert−ブチルジメチルシリルクロリド 3
2mg、トリエチルアミン(29ml)を加え、室温で
9時間撹拌した。水にあけ酢酸エチルで抽出し、得られ
た有機層をKHSO溶液、NaHCO水溶液、飽和
食塩水で洗浄した。無水硫酸ナトリウムで乾燥後、溶媒
を留去して、目的物を含む残渣 62.1gを得た。こ
のようにして得られた化合物を塩化メチレン(170m
l)に溶解し、氷冷下、メタンスルホニルクロリド(1
3.1ml)、トリエチルアミン(23.6ml)を順
次加えた。20分後、酢酸エチルで希釈した後、有機層
をKHSO溶液、NaHCO水溶液、飽和食塩水で
洗浄した。無水硫酸ナトリウムで洗浄後、溶媒を留去
し、得られた残渣をシリカゲルカラムクロマトグラフィ
ーで精製し、目的化合物(2)29.5gを得た。
[Chemical 9] (1'R, 2'R, 3S, 4R) -3- (1'-ter
t-butyldimethylsilyloxyethyl) -4- (2 '
-Tetrahydrofurylcarbonylthio) azetidinone (1) in a solution of 70.0 g in methanol under ice-cooling 4NH
160 ml of Cl / dioxane solution was added and stirred for 2.5 hours. This solution was poured into an aqueous solution of NaHCO 3 (50 g) (500 ml) and extracted with ethyl acetate. Anhydrous M
After drying with gSO 4 , the solvent was distilled off, and the residue containing the desired product 4
0.1 g was obtained. This was dissolved in 320 ml of methylene chloride and tert-butyldimethylsilyl chloride 3
2 mg and triethylamine (29 ml) were added, and the mixture was stirred at room temperature for 9 hours. The mixture was poured into water and extracted with ethyl acetate, and the obtained organic layer was washed with KHSO 4 solution, NaHCO 3 aqueous solution, and saturated saline. After drying over anhydrous sodium sulfate, the solvent was distilled off to obtain 62.1 g of a residue containing the desired product. The compound thus obtained was converted into methylene chloride (170 m
l) and dissolved in methanesulfonyl chloride (1
3.1 ml) and triethylamine (23.6 ml) were sequentially added. After 20 minutes, the mixture was diluted with ethyl acetate, and the organic layer was washed with KHSO 4 solution, NaHCO 3 aqueous solution, and saturated saline. After washing with anhydrous sodium sulfate, the solvent was distilled off, and the obtained residue was purified by silica gel column chromatography to obtain 29.5 g of the objective compound (2).

【0013】NMR(CDCl/TMS,δpp
m):0.21(s,3H),0.26(s,3H),
0.921(s,9H),1.69(d,3H,J=7
Hz),1.90−2.40(m,4H),3.90−
4.15(m,2H),4.50(dd,1H,J=4
Hz,8Hz),5.90(s,1H),6.19
(q,1H,J=6Hz)
NMR (CDCl 3 / TMS, δpp
m): 0.21 (s, 3H), 0.26 (s, 3H),
0.921 (s, 9H), 1.69 (d, 3H, J = 7
Hz), 1.90-2.40 (m, 4H), 3.90-
4.15 (m, 2H), 4.50 (dd, 1H, J = 4
Hz, 8 Hz), 5.90 (s, 1H), 6.19
(Q, 1H, J = 6Hz)

【0014】参考例2 (2’R,4R)−3−(2,2,2−トリクロロエト
キシカルボニルメチレン)−4−(2’−テトラヒドロ
フリルカルボニルチオ)−1−tert−ブチルジメチ
ルシリルアゼチジノン(3)の合成:
Reference Example 2 (2'R, 4R) -3- (2,2,2-trichloroethoxycarbonylmethylene) -4- (2'-tetrahydrofurylcarbonylthio) -1-tert-butyldimethylsilylazetidinone Synthesis of (3):

【化10】 参考例1で得られた化合物(2)50.3gのエーテル
(500ml)溶液に、0.25M リン酸バッファー
(500ml)、NaIO(97g)、OsO
(2.5g)を順次加えた。室温で2.5時間撹拌
後、水層を酢酸エチルで抽出した。得られた有機層を水
洗し、無水硫酸ナトリウムで乾燥後、溶媒を留去して得
られた残渣 48.9gのうち33,5gを取り、この
塩化メチレン(204ml)溶液に、室温でトリフェニ
ルフォスフォラニリデン酢酸2,2,2−トリクロロエ
チルエステル(46.1g)を加え、1時間撹拌した。
溶媒を留去後、シリカゲルカラムクロマトグラフィーで
精製し、目的化合物(3)を2種の異性体の混合物とし
て 16.7g得た。
[Chemical 10] To a solution of 50.3 g of the compound (2) obtained in Reference Example 1 in ether (500 ml) was added 0.25M phosphate buffer (500 ml), NaIO 4 (97 g), OsO.
4 (2.5 g) were added sequentially. After stirring at room temperature for 2.5 hours, the aqueous layer was extracted with ethyl acetate. The obtained organic layer was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off to obtain 34.9 g of 48.9 g of the resulting residue, which was added to this methylene chloride (204 ml) solution at room temperature with triphenyl ether. Phosphoranilidene acetic acid 2,2,2-trichloroethyl ester (46.1 g) was added, and the mixture was stirred for 1 hour.
After evaporating the solvent, the residue was purified by silica gel column chromatography to obtain 16.7 g of the target compound (3) as a mixture of two isomers.

【0005】NMR(CDCl/TMS,δpp
m):異性体A 0.26(s,3H),0.29(s,3H),0.9
9(s,9H),1.90−2.40(m,4H),
3.90−4.20(m,2H),4.45−4.55
(m,1H),4.85(d,1H,J=2Hz),
5.81(d,1H,J=1Hz),6.03(d,1
H,J=1Hz) NMR(CDCl/TMS,δppm):異性体B 0.25(s,3H),0.29(s,3H),0.9
8(s,9H),1.85−2.00(m,2H),
2.10−2.40(m,2H),3.90−4.00
(m,2H),3.50−3.60(m,1H),4,
67(d,1H,J=12Hz),4.86(d,1
H,J=12Hz)6.15(d,1H,J=2H
z),6.38(d,1H,J=2Hz)
NMR (CDCl 3 / TMS, δpp
m): Isomer A 0.26 (s, 3H), 0.29 (s, 3H), 0.9
9 (s, 9H), 1.90-2.40 (m, 4H),
3.90-4.20 (m, 2H), 4.45-4.55
(M, 1H), 4.85 (d, 1H, J = 2Hz),
5.81 (d, 1H, J = 1 Hz), 6.03 (d, 1
H, J = 1 Hz) NMR (CDCl 3 / TMS, δppm): Isomer B 0.25 (s, 3H), 0.29 (s, 3H), 0.9
8 (s, 9H), 1.85-2.00 (m, 2H),
2.10-2.40 (m, 2H), 3.90-4.00
(M, 2H), 3.50-3.60 (m, 1H), 4,
67 (d, 1H, J = 12 Hz), 4.86 (d, 1)
H, J = 12 Hz) 6.15 (d, 1H, J = 2H
z), 6.38 (d, 1H, J = 2Hz)

【0006】参考例3 (2’R,4R)−3−(2,2,2−トリクロロエト
キシカルボニルメチル)−4−(2’−テトラヒドロフ
リルカルボニルチオ)−1−tert−ブチルジメチル
シリルアゼチジノン(4)の合成:
Reference Example 3 (2'R, 4R) -3- (2,2,2-trichloroethoxycarbonylmethyl) -4- (2'-tetrahydrofurylcarbonylthio) -1-tert-butyldimethylsilylazetidinone Synthesis of (4):

【化11】 テルル粉末(350mg)、NaBH(240mg)
のエタノール懸濁液を15分間加熱還流した後、−50
℃に冷却し、酢酸(320μl)のエタノール溶液、続
いて、参考例2で得られた化合物(3)540mgのエ
タノール溶液を加えた。同温度で15分間撹拌後、pH
7のリン酸バッファーを加え、水層をさらに酢酸エチル
で抽出した。得られた有機層を無水硫酸ナトリウムで乾
燥後、溶媒を留去し、得られた残渣をシリカゲルカラム
クロマトグラフィーで精製し、目的化合物(4) 23
8mgを得た。(収率:43%)
[Chemical 11] Tellurium powder (350 mg), NaBH 4 (240 mg)
After heating the ethanol suspension of above under reflux for 15 minutes, -50
After cooling to 0 ° C., an ethanol solution of acetic acid (320 μl) was added, followed by an ethanol solution of 540 mg of the compound (3) obtained in Reference Example 2. After stirring for 15 minutes at the same temperature, pH
The phosphate buffer of 7 was added, and the aqueous layer was further extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated, and the obtained residue was purified by silica gel column chromatography to obtain the target compound (4) 23
8 mg was obtained. (Yield: 43%)

【0017】NMR(CDCl/TMS,δpp
m):2種の異性体の混合物として [0.23(s),0.24(s),0.25(s),
0.26(s);6H],1.85−2.30(m,4
H),2.73−3.10(m,2H),3.90−
4.25(m,3H),4.40−4.50(m,1
H),[4.71(s),4,75(d,J=3H
z);2H],[5.10(d,J=2Hz),5.5
3(d,J=7Hz);1H]
NMR (CDCl 3 / TMS, δpp
m): as a mixture of two isomers [0.23 (s), 0.24 (s), 0.25 (s),
0.26 (s); 6H], 1.85-2.30 (m, 4
H), 2.73-3.10 (m, 2H), 3.90-
4.25 (m, 3H), 4.40-4.50 (m, 1
H), [4.71 (s), 4,75 (d, J = 3H
z); 2H], [5.10 (d, J = 2 Hz), 5.5.
3 (d, J = 7 Hz); 1H]

【0018】参考例4 (2’R,4R)−3−(2,2,2−トリクロロエト
キシカルボニルメチル)−4−(2’−テトラヒドロフ
リルカルボニルチオ)アゼチジノン(5)の合成
Reference Example 4 Synthesis of (2'R, 4R) -3- (2,2,2-trichloroethoxycarbonylmethyl) -4- (2'-tetrahydrofurylcarbonylthio) azetidinone (5)

【化12】 参考例3で得られた化合物(4)2.0gのアセトニト
リル(40ml)溶液に、HF水溶液(48%,2.6
ml)を室温で加え、35分間撹拌した。反応液にNa
HCO水溶液を加えた後、塩化メチレンで抽出した。
有機層を無水硫酸ナトリウムで乾燥後、溶媒を留去して
得られた残渣をシリカゲルクロマトグラフィーで精製
し、目的化合物(5) 1250mgを得た。(収率:
81%)
[Chemical 12] A solution of 2.0 g of the compound (4) obtained in Reference Example 3 in acetonitrile (40 ml) was added to an aqueous HF solution (48%, 2.6%).
ml) was added at room temperature and stirred for 35 minutes. Na in the reaction solution
After adding HCO 3 aqueous solution, it was extracted with methylene chloride.
The organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated, and the obtained residue was purified by silica gel chromatography to obtain 1250 mg of the target compound (5). (yield:
81%)

【0019】NMR(CDCl/TMS,δpp
m):2種の異性体の混合物として 1.90−2.10(m,3H),2.20−2.40
(m,1H)2.85−3.15(m,2H),[3.
50−3.60(m),3.90−4.20(m);3
H],4.40−4.50(m,1H),4.70−
4.85(m,2H),[5.02(d,J=2H
z),5.41(d,J=5HZ);1H],[6.3
0(br.s),6.40(br.s);1H]
NMR (CDCl 3 / TMS, δpp
m): 1.90-2.10 (m, 3H), 2.20-2.40 as a mixture of two isomers.
(M, 1H) 2.85-3.15 (m, 2H), [3.
50-3.60 (m), 3.90-4.20 (m); 3
H], 4.40-4.50 (m, 1H), 4.70-
4.85 (m, 2H), [5.02 (d, J = 2H
z), 5.41 (d, J = 5HZ); 1H], [6.3.
0 (br.s), 6.40 (br.s); 1H]

【0020】参考例5 (5R,6R,2’R)−6−(2,2,2−トリクロ
ロエチルオキシカルボニルメチル)−2−(2,−テト
ラヒドロフリル)ペネム−カルボン酸アリルエステル
(6)の合成:
Reference Example 5 (5R, 6R, 2'R) -6- (2,2,2-trichloroethyloxycarbonylmethyl) -2- (2, -tetrahydrofuryl) penem-carboxylic acid allyl ester (6) Synthesis of:

【化13】 参考例4で得られた化合物(5) 534mgの塩化メ
チレン溶液(1.6ml)に、−20℃でアリルオキザ
リルクロリド(247μl)、トリエチルアミン(28
5μl)を加えた。すぐに反応液にKHSO水溶液を
加え、有機層を水洗後、無水硫酸ナトリウムで乾燥し
た。溶媒を留去して得られた残渣にキシレン26ml、
トリエチルフォスファイト(440μl)を加え、1時
間加熱還流した。溶媒を留去し得られた残渣をシリカゲ
ルカラムクロマトグラフィーで精製し、目的化合物
(6) 95mgを得た。(収率:15%)
[Chemical 13] A compound (5) obtained in Reference Example 4 (534 mg) in a methylene chloride solution (1.6 ml) was added to allyl oxalyl chloride (247 µl) and triethylamine (28) at -20 ° C.
5 μl) was added. Immediately, an aqueous KHSO 4 solution was added to the reaction solution, the organic layer was washed with water, and then dried over anhydrous sodium sulfate. 26 ml of xylene was added to the residue obtained by distilling off the solvent.
Triethyl phosphite (440 μl) was added, and the mixture was heated under reflux for 1 hr. The solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 95 mg of the target compound (6). (Yield: 15%)

【0021】IR(neat,cm−1):1790,
1755,1706,1319 NMR(CDCl/TMS,δppm):1.80−
2.10(m,3H),2.40−2.55(m,1
H),3.10−3.35(m,2H),3.80−
4.05(m,2H),6.20−6.30(m,1
H),4.60−5.90(m,4H),5.25−
5.45(m,3H),5.75(m,1H,J=4H
z),5.85−6.05(m,1H)
IR (neat, cm -1 ): 1790,
1755, 1706, 1319 NMR (CDCl 3 / TMS, δppm): 1.80-
2.10 (m, 3H), 2.40-2.55 (m, 1
H), 3.10-3.35 (m, 2H), 3.80-
4.05 (m, 2H), 6.20-6.30 (m, 1
H), 4.60-5.90 (m, 4H), 5.25-
5.45 (m, 3H), 5.75 (m, 1H, J = 4H
z), 5.85-6.05 (m, 1H)

【0022】参考例6 (2’R,4R)−3−(アリルオキシカルボニルメチ
レン)−4−(2’−テトラヒドロフリルカルボニルチ
オ)−1−tert−ブチルジメチルシリルアゼチジノ
ン(7)の合成:
Reference Example 6 Synthesis of (2'R, 4R) -3- (allyloxycarbonylmethylene) -4- (2'-tetrahydrofurylcarbonylthio) -1-tert-butyldimethylsilylazetidinone (7):

【化14】 参考例1で得られた化合物(2) 31.5gを用い
て、参考例2と同様にして合成し、目的化合物(7)
9.93gを得た。(収率:26%)
[Chemical 14] The target compound (7) was synthesized in the same manner as in Reference Example 2 using 31.5 g of the compound (2) obtained in Reference Example 1.
Obtained 9.93 g. (Yield: 26%)

【0023】IR(neat,Cm−1):1759,
1726,1698 NMR (CDCl/TMS,δppm):0.24
(s,3H),0.28(s,3H),0.98(s,
9H),1.84−2.00(m,2H),2.11−
2.32(m,2H),3.88−4.06(m,2
H),4.48−4.64(m,3H),5.21−
5.34(m,2H),5.81−5.98(m,1
H),6.14(s,1H),6.26(s,1H)
IR (neat, Cm -1 ): 1759,
1726, 1698 NMR (CDCl 3 / TMS, δppm): 0.24
(S, 3H), 0.28 (s, 3H), 0.98 (s,
9H), 1.84-2.00 (m, 2H), 2.11-
2.32 (m, 2H), 3.88-4.06 (m, 2)
H), 4.48-4.64 (m, 3H), 5.21-
5.34 (m, 2H), 5.81-5.98 (m, 1
H), 6.14 (s, 1H), 6.26 (s, 1H)

【0024】参考例7 (2’R,4R)−3−(アリルオキシカルボニルメチ
ル)−4−(2’−テトラヒドロフリルカルボニルチ
オ)−1−tert−ブチルジメチルシリルアゼチジノ
ン(8)の合成:
Reference Example 7 Synthesis of (2'R, 4R) -3- (allyloxycarbonylmethyl) -4- (2'-tetrahydrofurylcarbonylthio) -1-tert-butyldimethylsilylazetidinone (8):

【化15】 参考例6で得られた化合物(7)9.93mgを用いて
参考例3と同様に合成し、目的化合物(8) 6.94
gを得た。(収率:88%)
[Chemical 15] The target compound (8) 6.94 was synthesized in the same manner as in Reference Example 3 using 9.93 mg of the compound (7) obtained in Reference Example 6.
g was obtained. (Yield: 88%)

【0025】IR(neat,cm−1):1760,
1694 NMR (CDCl/TMS,δppm):2種の異
性体の混合物として [0.18−0.28(s);6H],0.96(s,
9H),1.82−2.32(m,4H),2.60−
2.98(m,2H),[3.51−3.61(m),
3.89−4.21(m);3H],4.40−4.6
2(m,3H),5.15−5.37(m,2H),
[5.12(d,J=2.6Hz),5.52(d,J
=5.3Hz);1H],5.81−6.00(m,1
H)
IR (neat, cm -1 ): 1760,
1694 NMR (CDCl 3 / TMS, δppm): [0.18-0.28 (s); 6H], 0.96 (s, as a mixture of two isomers.
9H), 1.82-2.32 (m, 4H), 2.60-
2.98 (m, 2H), [3.51 to 3.61 (m),
3.89-4.21 (m); 3H], 4.40-4.6.
2 (m, 3H), 5.15-5.37 (m, 2H),
[5.12 (d, J = 2.6 Hz), 5.52 (d, J
= 5.3 Hz); 1H], 5.81-6.00 (m, 1
H)

【0026】参考例8 (2’R,4R)−3−(アリルオキシカルボニルメチ
ル)−4−(2’−テトラヒドロフリルカルボニルチ
オ)アゼチジノン(9)の合成:
Reference Example 8 Synthesis of (2'R, 4R) -3- (allyloxycarbonylmethyl) -4- (2'-tetrahydrofurylcarbonylthio) azetidinone (9):

【化16】 参考例7で得られた化合物(8) 3.94gを用い
て、参考例4と同様に合成し、目的化合物(9) 2.
58gを得た。(収率:90%)
[Chemical 16] The target compound (9) was synthesized in the same manner as in Reference Example 4 using 3.94 g of the compound (8) obtained in Reference Example 7.
58 g were obtained. (Yield: 90%)

【0027】IR(neat,cm−1):3283,
1774,1734,1684 NMR (CDCl/TMS,δppm):2種の異
性体の混合物として 1.86−2.35(m,4H),2.69−3.00
(m,2H),[3,48−3.56(m),3.90
−4.17(m);3H],4.47(dd,1H,J
=8.6Hz,4.6Hz),4.61(d,2H,J
=5.3Hz),5.24(d,1H,J=10.6H
z),5.33(d,1H,J=17.2Hz),
[4.99(d,J=10.6Hz),5.42(d,
J=5.3Hz)1H],5.82−6.00(m,1
H),[6.23(br.s),6.35(br.
s),1H]
IR (neat, cm -1 ): 3283,
1774, 1734, 1684 NMR (CDCl 3 / TMS, δppm): 1.86-2.35 (m, 4H), 2.69-3.00 as a mixture of two isomers.
(M, 2H), [3,48-3.56 (m), 3.90
-4.17 (m); 3H], 4.47 (dd, 1H, J
= 8.6 Hz, 4.6 Hz), 4.61 (d, 2H, J
= 5.3 Hz), 5.24 (d, 1H, J = 10.6H)
z), 5.33 (d, 1H, J = 17.2 Hz),
[4.99 (d, J = 10.6 Hz), 5.42 (d,
J = 5.3 Hz) 1H], 5.82-6.00 (m, 1
H), [6.23 (br.s), 6.35 (br.
s), 1H]

【0028】参考例9 (2’R,5R)−6−アリルオキシカルボニルメチル
−2−(2’−テトラヒドロフリル)ペネム−カルボン
酸アリルエステル(10)及び(11)の合成:
Reference Example 9 Synthesis of (2'R, 5R) -6-allyloxycarbonylmethyl-2- (2'-tetrahydrofuryl) penem-carboxylic acid allyl ester (10) and (11):

【化17】 参考例8で得られた化合物(9) 897mgの塩化メ
チレン溶液(1.6ml)に、−20℃でアリルオキザ
リルクロリド(533μl)、トリエチルアミン(61
8μl)を加えた。同温度で、1時間撹拌後、酢酸エチ
ルで希釈し、NaHCO水溶液、飽和食塩水で洗浄し
た。無水硫酸ナトリウムで乾燥後、溶媒を留去した。得
られた残渣にキシレン 60ml、トリエチルフォスフ
ァイト(1.29ml)を加え、3時間加熱還流した。
溶媒を留去して得られた残渣をシリカゲルクラマトグラ
フィーで精製し、目的化合物(10)及び(11) 3
00mgを得た。(収率:24%)
[Chemical 17] Compound (9) obtained in Reference Example 8 To a solution of 897 mg of methylene chloride (1.6 ml) was added allyl oxalyl chloride (533 µl) and triethylamine (61) at -20 ° C.
8 μl) was added. After stirring at the same temperature for 1 hour, the mixture was diluted with ethyl acetate and washed with an aqueous NaHCO 3 solution and saturated saline. After drying over anhydrous sodium sulfate, the solvent was distilled off. Xylene (60 ml) and triethylphosphite (1.29 ml) were added to the obtained residue, and the mixture was heated under reflux for 3 hours.
The solvent was distilled off and the obtained residue was purified by silica gel chromatography to obtain the target compounds (10) and (11) 3.
Obtained 00 mg. (Yield: 24%)

【0029】化合物(10) IR(neat,cm−1):(5R,6R)体 1790,1731,1703 NMR(CDCl/TMS,δppm):(5R,6
R)体 1.75−2.09(m,3H),2.39−2.55
(m,1H),2.97(dd,1H,J=4.6H
z,17.2Hz),3.14(dd,1H,J=1
1.9Hz,17.2Hz),3.80−4.04
(m,2H),4.15−4.24(m,1H),4.
57−4.87(m,4H),5.22−5.45
(m,5H),5.74(d,1H,J=4.0H
z),5.81−6.02(m,2H) 化合物(11) IR(neat,cm−1):(5R,6S)体 1792,1736,1706 NMR(CDCl/TMS,δppm):(5R,6
S)体 1.89−2.10(m,2H),1.70−1.89
(m,1H),2.36−2.51(m,1H),2.
80(dd,1H,J=4.6Hz,17.8Hz),
2.98(dd,1H,J=11.2Hz,17.8H
z),3.79−4.09(m,3H),4.55−
4.90(m,4H),5.21−5.49(m,6
H),5.81−6.04(m,2H)
Compound (10) IR (neat, cm -1 ): (5R, 6R) form 1790, 1731, 1703 NMR (CDCl 3 / TMS, δppm): (5R, 6)
R) form 1.75-2.09 (m, 3H), 2.39-2.55
(M, 1H), 2.97 (dd, 1H, J = 4.6H
z, 17.2 Hz), 3.14 (dd, 1H, J = 1
1.9 Hz, 17.2 Hz), 3.80-4.04
(M, 2H), 4.15-4.24 (m, 1H), 4.
57-4.87 (m, 4H), 5.22-5.45
(M, 5H), 5.74 (d, 1H, J = 4.0H
z), 5.81-6.02 (m, 2H) compound (11) IR (neat, cm -1 ): (5R, 6S) body 1792, 1736, 1706 NMR (CDCl 3 / TMS, δppm): ( 5R, 6
S) body 1.89-2.10 (m, 2H), 1.70-1.89
(M, 1H), 2.36-2.51 (m, 1H), 2.
80 (dd, 1H, J = 4.6Hz, 17.8Hz),
2.98 (dd, 1H, J = 11.2Hz, 17.8H
z), 3.79-4.09 (m, 3H), 4.55-
4.90 (m, 4H), 5.21-5.49 (m, 6
H), 5.81-6.04 (m, 2H)

【0030】実施例1 (5R,6R,2’R)−2−アリルオキシカルボニル
−8−オキソ−3−(2’−テトラヒドロフリル)−1
−アザ−4−チアビシクロ[3.3.0]オクト−2−
エン−6−カルボン酸(12)の合成:
Example 1 (5R, 6R, 2'R) -2-allyloxycarbonyl-8-oxo-3- (2'-tetrahydrofuryl) -1
-Aza-4-thiabicyclo [3.3.0] oct-2-
Synthesis of ene-6-carboxylic acid (12):

【化18】 (5R,6R,2’R)−6−(2,2,2−トリクロ
ロエチルオキシカルボニルメチル)−2−(2’−テト
ラヒドロフリル)ペネム−カルボン酸アリルエステル
(6) 40mg(0.085mmol)のテトラヒド
ロフラン溶液(1ml)に、1M KHPO(1m
l)を加え、これに亜鉛末(400mg)を加えた。4
5分間室温で激しく撹拌後、50%酢酸−水 3mlを
加え、不溶物を瀘別した後、そのままHPLCで精製
し、標記化合物(12) 4.6mgを得た。(収率:
16%)
[Chemical 18] (5R, 6R, 2′R) -6- (2,2,2-trichloroethyloxycarbonylmethyl) -2- (2′-tetrahydrofuryl) penem-carboxylic acid allyl ester (6) 40 mg (0.085 mmol) In tetrahydrofuran solution (1 ml) of 1M KH 2 PO 4 (1 m
1) was added, and zinc dust (400 mg) was added thereto. Four
After stirring vigorously for 5 minutes at room temperature, 50% acetic acid-water (3 ml) was added, the insoluble matter was filtered off, and the product was directly purified by HPLC to obtain 4.6 mg of the title compound (12). (yield:
16%)

【0031】IR(film,cm−1):1732,
1716,1374,1325,1259,1188 NMR(CDCl/TMS,δppm):1.70−
2.10(m,3H),2.35−2.50(m,1
H),2.80−3.00(m,1H),3.00−
3.15(m,1H),3.60−4.10(m,3
H),4.65−4.80(m,2H),5.25−
5.50(m,3H),5.90−6.50(m,2
H)
IR (film, cm -1 ): 1732
1716, 1374, 1325, 1259, 1188 NMR (CDCl 3 / TMS, δppm): 1.70-
2.10 (m, 3H), 2.35-2.50 (m, 1
H), 2.80-3.00 (m, 1H), 3.00-
3.15 (m, 1H), 3.60-4.10 (m, 3
H), 4.65-4.80 (m, 2H), 5.25-
5.50 (m, 3H), 5.90-6.50 (m, 2
H)

【0032】実施例2 (5R,6R,2’R)−2−アリルオキシカルボニル
−6−ベンジルアミノカルボニル−8−オキソ−3−
(2’−テトラヒドロフリル)−1−アザ−4−チアビ
シクロ[3.3.0]オクト−2−エン(13)の合
成:
Example 2 (5R, 6R, 2'R) -2-allyloxycarbonyl-6-benzylaminocarbonyl-8-oxo-3-
Synthesis of (2'-tetrahydrofuryl) -1-aza-4-thiabicyclo [3.3.0] oct-2-ene (13):

【化19】 実施例1で得られた化合物(12) 7mg(0.02
mmol)の塩化メチレン溶液(0.2ml)に、室温
でN−エチル−N’−ジエチルアミノエチルカルボジイ
ミド塩酸塩(4.3mg)、ベンジルアミン(2.5m
g)、N−ヒドロキシベンゾトリアゾール(2.5m
g)を順次加え、30分間撹拌した。酢酸エチルで希釈
後、飽和KHSO、飽和重曹水、飽和食塩水で順次洗
浄し、無水硫酸ナトリウムで乾燥した。溶媒を減圧下留
去し、標記化合物(13)(8mg)を得た。(収率:
93%)
[Chemical 19] 7 mg (0.02) of the compound (12) obtained in Example 1
mmol) in methylene chloride solution (0.2 ml) at room temperature in N-ethyl-N'-diethylaminoethylcarbodiimide hydrochloride (4.3 mg), benzylamine (2.5 m).
g), N-hydroxybenzotriazole (2.5 m
g) were sequentially added and stirred for 30 minutes. The mixture was diluted with ethyl acetate, washed successively with saturated KHSO 4 , saturated aqueous sodium hydrogen carbonate and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to give the title compound (13) (8 mg). (yield:
93%)

【0033】IR(film,cm−1):3304,
2924,1719,1654,1369,1324,
1260,1183 NMR(CDCl/TMS,δppm):1.65−
2.10(m,3H),2.30−2.45(m,1
H),2.72(dd,J=16Hz,9Hz),3.
06(dd,J=16Hz,9Hz),3.49(d
t,J=9Hz,6Hz),3.80(dd,J=13
Hz,7Hz),3.93(dd,J=15Hz,7H
z),4.44−4.50(m,2H),4.62−
4.78(m,2H),5.23−5.43(m,3
H),5.85−6.03(m,3H),6.10−
6.20(1H)
IR (film, cm -1 ): 3304,
2924, 1719, 1654, 1369, 1324,
1260, 1183 NMR (CDCl 3 / TMS, δppm): 1.65
2.10 (m, 3H), 2.30-2.45 (m, 1
H), 2.72 (dd, J = 16 Hz, 9 Hz), 3.
06 (dd, J = 16 Hz, 9 Hz), 3.49 (d
t, J = 9 Hz, 6 Hz), 3.80 (dd, J = 13)
Hz, 7 Hz), 3.93 (dd, J = 15 Hz, 7H
z), 4.44-4.50 (m, 2H), 4.62-
4.78 (m, 2H), 5.23-5.43 (m, 3
H), 5.85-6.03 (m, 3H), 6.10-
6.20 (1H)

【0034】実施例3 (5R,6R,2’R)−6−ベンジルアミノカルボニ
ル−8−オキソ−3−(2’−テトラヒドロフリル)−
1−アザ−4−チアビシクロ[3.3.0]オクト−2
−エン−2−カルボン酸ナトリウム(14)の合成:
Example 3 (5R, 6R, 2'R) -6-Benzylaminocarbonyl-8-oxo-3- (2'-tetrahydrofuryl)-
1-aza-4-thiabicyclo [3.3.0] oct-2
-Synthesis of sodium ene-2-carboxylate (14):

【化20】 実施例2で得られた化合物(13) 9mg(0.02
mmol)のテトラヒドロフラン溶液(200μl)
に、2−エチルヘキサン酸 ナトリウム塩(3mg)、
トリフェニルフォスフィン(2mg)、テトラキストリ
フェニルフォスフィンパラジウム(2mg)を順次加
え、室温で30分間撹拌した。反応液に水及び酢酸エチ
ルを加え、水層を酢酸エチルで洗浄した。得られた水層
を凍結乾燥し、標記化合物(14) 5mgを得た。
(収率:56%)
[Chemical 20] 9 mg (0.02) of the compound (13) obtained in Example 2
tetrahydrofuran solution (200 μl)
2-ethylhexanoic acid sodium salt (3 mg),
Triphenylphosphine (2 mg) and tetrakistriphenylphosphine palladium (2 mg) were sequentially added, and the mixture was stirred at room temperature for 30 minutes. Water and ethyl acetate were added to the reaction solution, and the aqueous layer was washed with ethyl acetate. The obtained aqueous layer was freeze-dried to obtain 5 mg of the title compound (14).
(Yield: 56%)

【0035】IR(film,cm−1) :170
0,1676,1560,1400 NMR(CDCl/TMS,δppm) :1.80
−2.20(m,3H),2.20−2.35(m,1
H),2.89(dd,1H,J=17Hz,9H
z),3.09(dd,1H,J=16Hz,9H
z),3.80−4.00(m,3H),4.43
(s,2H),5.33(t,J=7Hz),6.05
(d,1H,J=7Hz)
IR (film, cm -1 ): 170
0,1676,1560,1400 NMR (CDCl 3 / TMS, δppm): 1.80
-2.20 (m, 3H), 2.20-2.35 (m, 1)
H), 2.89 (dd, 1H, J = 17Hz, 9H
z), 3.09 (dd, 1H, J = 16Hz, 9H
z), 3.80-4.00 (m, 3H), 4.43.
(S, 2H), 5.33 (t, J = 7Hz), 6.05
(D, 1H, J = 7Hz)

【0036】実施例4 (5R,6R)−2−ベンジルオキシカルボニル−8−
オキソ−3,3−ジメチル−1−アザ−4−チアビシク
ロ[3.3.0]オクタン−6−カルボン酸(16)の
合成:
Example 4 (5R, 6R) -2-Benzyloxycarbonyl-8-
Synthesis of oxo-3,3-dimethyl-1-aza-4-thiabicyclo [3.3.0] octane-6-carboxylic acid (16):

【化21】 アルゴン雰囲気下、(5R,6R)−6−メトキシカル
ボニルメチル−7−オキソ−3,3−ジメチル−1−ア
ザ−4−チアビシクロ[3.2.0]ヘプタン−2−カ
ルボン酸ベンジルエステル(15) 363mg(1m
mol)のクロロホルム(10ml)溶液に、ヨードト
リメチルシラン(171μl)を室温で加え、90分間
撹拌した。酢酸エチルで希釈した後、飽和重曹水で抽出
した。水層を希塩酸でpH2とした後、塩化メチレンで
3回抽出し、得られた有機層を無水硫酸ナトリウムで乾
燥した。溶媒を減圧下留去し、標記化合物(16) 1
60mgを得た。(収率:46%)
[Chemical 21] Under an argon atmosphere, (5R, 6R) -6-methoxycarbonylmethyl-7-oxo-3,3-dimethyl-1-aza-4-thiabicyclo [3.2.0] heptane-2-carboxylic acid benzyl ester (15 ) 363 mg (1 m
mol) in chloroform (10 ml) was added with iodotrimethylsilane (171 μl) at room temperature and stirred for 90 minutes. After diluting with ethyl acetate, the mixture was extracted with saturated aqueous sodium hydrogen carbonate. The aqueous layer was adjusted to pH 2 with diluted hydrochloric acid, extracted with methylene chloride three times, and the obtained organic layer was dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to give the title compound (16) 1
60 mg was obtained. (Yield: 46%)

【0037】IR(film,cm−1):2756,
1732 NMR(CDCl/TMS,δppm):1.41
(s,3H),1.56(s,3H),2.85(d
d,1H,J=17Hz,10Hz),3.09(d
d,1H,J=17Hz,10Hz),4.64(s,
1H),5.20(q,2H,J=17Hz,12H
z),5.73(d,1H,J=7Hz),7.37
(s,5H)
IR (film, cm -1 ): 2756,
1732 NMR (CDCl 3 / TMS, δppm): 1.41
(S, 3H), 1.56 (s, 3H), 2.85 (d
d, 1H, J = 17 Hz, 10 Hz), 3.09 (d
d, 1H, J = 17 Hz, 10 Hz), 4.64 (s,
1H), 5.20 (q, 2H, J = 17Hz, 12H
z), 5.73 (d, 1H, J = 7 Hz), 7.37
(S, 5H)

【0038】実施例5 (5R,6R)−8−オキソ−3,3−ジメチル−1−
アザ−4−チアビシクロ[3.3.0]オクタン−2,
6−ジカルボン酸(17)の合成:
Example 5 (5R, 6R) -8-oxo-3,3-dimethyl-1-
Aza-4-thiabicyclo [3.3.0] octane-2,
Synthesis of 6-dicarboxylic acid (17):

【化22】 アルゴン雰囲気下、0℃にて実施例4で得られた化合物
(16) 45mg(0.13mmol)を塩化メチレ
ン(1ml)に溶解し、これにアニソール(81μ
l)、ニトロメタン(2ml)に溶解した塩化アルミニ
ウム(100mg)を順次加えた。室温でさらに2時間
撹拌後、酢酸エチルで希釈した。有機層を0.1N 塩
酸で洗浄後、飽和重曹水で抽出した。水層を希塩酸でp
H2とした後、酢酸エチルで3回抽出し、得られた有機
層を無水硫酸ナトリウムで乾燥した。溶媒を減圧下留去
し、標記化合物(17) 20mgを得た。(収率:5
9%)
[Chemical formula 22] Under an argon atmosphere, at 0 ° C., 45 mg (0.13 mmol) of the compound (16) obtained in Example 4 was dissolved in methylene chloride (1 ml), and anisole (81 μm) was added thereto.
1) and aluminum chloride (100 mg) dissolved in nitromethane (2 ml) were sequentially added. After stirring at room temperature for another 2 hours, the mixture was diluted with ethyl acetate. The organic layer was washed with 0.1N hydrochloric acid and then extracted with saturated aqueous sodium hydrogen carbonate. Water layer is diluted with diluted hydrochloric acid
After adjusting to H2, the mixture was extracted with ethyl acetate three times, and the obtained organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to obtain 20 mg of the title compound (17). (Yield: 5
9%)

【0039】NMR(CDCl/TMS,δppm) 1.47(s,3H),1.50(s,3H),2.7
0(dd,1H,J=16Hz,11Hz),2.90
(dd,1H,J=16Hz,11Hz),4.35
(s,1H),5.54(d,J=7Hz)
NMR (CDCl 3 / TMS, δppm) 1.47 (s, 3H), 1.50 (s, 3H), 2.7
0 (dd, 1H, J = 16Hz, 11Hz), 2.90
(Dd, 1H, J = 16Hz, 11Hz), 4.35
(S, 1H), 5.54 (d, J = 7Hz)

【0040】実施例6 (5R,6R)−6−ベンジルアミノカルボニル−8−
オキソ−3,3−ジメチル−1−アザ−4−チアビシク
ロ[3.3.0]オクタン−2−カルボン酸ベンジルエ
ステル(18)の合成:
Example 6 (5R, 6R) -6-Benzylaminocarbonyl-8-
Synthesis of oxo-3,3-dimethyl-1-aza-4-thiabicyclo [3.3.0] octane-2-carboxylic acid benzyl ester (18):

【化23】 氷冷下、実施例4で得られた化合物(16) 70mg
(0.20mmol)及びベンジルアミン(21mg)
の塩化メチレン(1ml)溶液に、N−エチル−N’−
ジメチルアミノプロピルカルボジイミド塩酸塩 42m
gを加えた。10分間撹拌後さらに室温で90分間撹拌
した。反応液を酢酸エチルで希釈後、飽和重硫酸カリウ
ム、飽和食塩水で洗浄し、有機層を無水硫酸ナトリウム
で乾燥した。溶媒を減圧下留去して得られた残渣をシリ
カゲルカラムクロマトグラフィーで精製し、標記化合物
(18) 63mgを得た。(収率:72%)
[Chemical formula 23] 70 mg of the compound (16) obtained in Example 4 under ice cooling
(0.20 mmol) and benzylamine (21 mg)
In methylene chloride (1 ml) solution of N-ethyl-N'-
Dimethylaminopropyl carbodiimide hydrochloride 42m
g was added. After stirring for 10 minutes, the mixture was further stirred at room temperature for 90 minutes. The reaction mixture was diluted with ethyl acetate, washed with saturated potassium bisulfate and saturated brine, and the organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 63 mg of the title compound (18). (Yield: 72%)

【0041】IR(film,cm−1):1712,
1684,1274 NMR(CDCl/TMS,δppm):1.39
(s,3H),1.52(s,3H),2.70(d
d,1H,J=16Hz,11Hz),3.10−3.
30(m,2H),4.40−4.50(m,2H),
4.63(s,1H),5.20(s,2H),5.6
8(d,1H,J=7Hz),6.85(br.s,1
H),7.25−7.40(m,10H)
IR (film, cm -1 ): 1712,
1684, 1274 NMR (CDCl 3 / TMS, δppm): 1.39.
(S, 3H), 1.52 (s, 3H), 2.70 (d
d, 1H, J = 16 Hz, 11 Hz), 3.10-3.
30 (m, 2H), 4.40-4.50 (m, 2H),
4.63 (s, 1H), 5.20 (s, 2H), 5.6
8 (d, 1H, J = 7 Hz), 6.85 (br.s, 1
H), 7.25-7.40 (m, 10H)

【0042】実施例7 (5R,6R)−6−ベンジルアミノカルボニル−8−
オキソ−3,3−ジメチル−1−アザ−4−チアビシク
ロ[3.3.0]オクタン−2−カルボン酸(19)の
合成:
Example 7 (5R, 6R) -6-Benzylaminocarbonyl-8-
Synthesis of oxo-3,3-dimethyl-1-aza-4-thiabicyclo [3.3.0] octane-2-carboxylic acid (19):

【化24】 実施例6で得られた化合物(18) 35mg(0.0
8mmol)を用いて実施例5と同様に反応させ、標記
化合物(19) 17mgを得た。(収率:61%)
[Chemical formula 24] 35 mg (0.0) of the compound (18) obtained in Example 6
8 mmol) was used and reacted in the same manner as in Example 5 to obtain 17 mg of the title compound (19). (Yield: 61%)

【0043】IR(film,cm−1):3294,
1732,1683,1635 NMR(CDCl/TMS,δppm):1.46
(s,3H),1.50(s,3H),2.70(d
d,1H,J=16Hz,9Hz),2.87(dd,
1H,J=16Hz,9Hz),4.31(d,2H,
J=5Hz),4.34(s,1H),7.20−7.
55(m,5H)
IR (film, cm -1 ): 3294,
1732, 1683, 1635 NMR (CDCl 3 / TMS, δppm): 1.46.
(S, 3H), 1.50 (s, 3H), 2.70 (d
d, 1H, J = 16Hz, 9Hz), 2.87 (dd,
1H, J = 16Hz, 9Hz), 4.31 (d, 2H,
J = 5 Hz), 4.34 (s, 1H), 7.20-7.
55 (m, 5H)

【0044】実施例8 (5R,6R)−6−カルバモイル−8−オキソ−3,
3−ジメチル−1−アザ−4−チアビシクロ[3.3.
0]オクタン−2−カルボン酸 ベンジルエステル(2
0)の合成:
Example 8 (5R, 6R) -6-carbamoyl-8-oxo-3,
3-Dimethyl-1-aza-4-thiabicyclo [3.3.
0] octane-2-carboxylic acid benzyl ester (2
Synthesis of 0):

【化25】 −20℃で、実施例4で得られた化合物(16) 20
mg(0.06mmol)の塩化メチレン(0.3m
l)溶液に、ブロモトリスピロリジノフォスフォニウム
ヘキサフルオロフォスフェート 32mg、アンモニ
アのDMF溶液200μl(0.28mmol)を順次
加えた。室温で5時間撹拌後、酢酸エチルで反応液を希
釈し、飽和重硫酸カリウム、飽和食塩水で洗浄して、有
機層を無水硫酸ナトリウムで乾燥した。溶媒を減圧下留
去して得られた残渣をシリカゲルカラムクロマトグラフ
ィーで精製し、標記化合物(20) 17mgを得た。
(収率:85%)
[Chemical 25] Compound (16) 20 obtained in Example 4 at −20 ° C.
mg (0.06 mmol) of methylene chloride (0.3 m
l) To the solution, 32 mg of bromotris-pyrrolidinophosphonium hexafluorophosphate and 200 μl (0.28 mmol) of a DMF solution of ammonia were sequentially added. After stirring at room temperature for 5 hours, the reaction solution was diluted with ethyl acetate, washed with saturated potassium bisulfate and saturated saline, and the organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 17 mg of the title compound (20).
(Yield: 85%)

【0045】IR(film,cm−1):1734,
1684,1188 NMR(CDCl/TMS,δppm)1.41
(s,3H),1.54(s,3H),2.71(q,
1H,J=22Hz,14Hz),3.10−3.25
(m,2H),4.64(s,1H),5.20(s,
2H),5.66(d,1H,J=6Hz),7.37
(s,5H)
IR (film, cm -1 ): 1734
1684, 1188 NMR (CDCl 3 / TMS, δppm) 1.41
(S, 3H), 1.54 (s, 3H), 2.71 (q,
1H, J = 22Hz, 14Hz), 3.10-3.25.
(M, 2H), 4.64 (s, 1H), 5.20 (s,
2H), 5.66 (d, 1H, J = 6Hz), 7.37
(S, 5H)

【0046】実施例9 (5R,6R)−6−(2−フリルメチル)アミノカル
ボニル−8−オキソ−3,3−ジメチル−1−アザ−4
−チアビシクロ[3.3.0]オクタン−2−カルボン
酸 ベンジルエステル(21)の合成:
Example 9 (5R, 6R) -6- (2-furylmethyl) aminocarbonyl-8-oxo-3,3-dimethyl-1-aza-4
-Synthesis of thiabicyclo [3.3.0] octane-2-carboxylic acid benzyl ester (21):

【化26】 実施例4で得られた化合物(16) 420mg(1.
20mmol)を用い、アミンとしてフルフリルアミン
117mgを用いて、実施例6と同様に反応を行い、
標記化合物(21) 304mgを得た。(収率:59
%)
[Chemical formula 26] 420 mg of the compound (16) obtained in Example 4 (1.
20 mmol) and 117 mg of furfurylamine as an amine to carry out a reaction in the same manner as in Example 6,
304 mg of the title compound (21) was obtained. (Yield: 59
%)

【0047】IR(film,cm−1):3298,
1744,1710,1543,1374 NMR(CDCl/TMS,δppm)1.39
(s,3H),1.52(s,3H),2.65(d
d,1H,J=14Hz,2Hz),3.07−3.2
7(m,2H),4.47(ABdq,2H,J=25
Hz,15Hz,5Hz),4.63(s,1H),
5.19(s,2H),5.65(d,1H,J=6H
z),5.89(br.s,1H),6.24−6.2
5(m,1H),6.32−6.65(m,1H),
7.38(s,6H)
IR (film, cm -1 ): 3298,
1744, 1710, 1543, 1374 NMR (CDCl 3 / TMS, δppm) 1.39
(S, 3H), 1.52 (s, 3H), 2.65 (d
d, 1H, J = 14 Hz, 2 Hz), 3.07-3.2
7 (m, 2H), 4.47 (ABdq, 2H, J = 25
Hz, 15Hz, 5Hz), 4.63 (s, 1H),
5.19 (s, 2H), 5.65 (d, 1H, J = 6H
z), 5.89 (br.s, 1H), 6.24-6.2.
5 (m, 1H), 6.32-6.65 (m, 1H),
7.38 (s, 6H)

【0048】実施例10 (5R,6R)−6−(2−フリルメチル)アミノカル
ボニル−8−オキソ−3,3−ジメチル−1−アザ−4
−チアビシクロ[3.3.0]オクタン−2−カルボン
酸(22)の合成:
Example 10 (5R, 6R) -6- (2-Furylmethyl) aminocarbonyl-8-oxo-3,3-dimethyl-1-aza-4
-Synthesis of thiabicyclo [3.3.0] octane-2-carboxylic acid (22):

【化27】 実施例9で得られた化合物(21) 97mg(0.2
3mmol)を用いて、実施例5と同様に反応させ、標
記化合物(22) 66mgを得た。(収率:86%)
[Chemical 27] 97 mg (0.2) of the compound (21) obtained in Example 9
(3 mmol) was used and reacted in the same manner as in Example 5 to obtain 66 mg of the title compound (22). (Yield: 86%)

【0049】NMR(DMSO−d6/TMS,δpp
m):1.46(s,3H),1.49(s,3H),
2.67(dd,1H,J=17Hz,10Hz),
2.79(dd,1H,J=16Hz,7Hz),4.
29(d,2H,J=6Hz),4.33(s,1
H),5.49(d,1H,J=6Hz),6.24
(d,1H,J=2Hz),6.38−6.39(m,
1H),7.58(s,1H),8.70(br.t,
1H)
NMR (DMSO-d6 / TMS, δpp
m): 1.46 (s, 3H), 1.49 (s, 3H),
2.67 (dd, 1H, J = 17Hz, 10Hz),
2.79 (dd, 1H, J = 16Hz, 7Hz), 4.
29 (d, 2H, J = 6 Hz), 4.33 (s, 1
H), 5.49 (d, 1H, J = 6 Hz), 6.24
(D, 1H, J = 2 Hz), 6.38-6.39 (m,
1H), 7.58 (s, 1H), 8.70 (br.t,
1H)

【0050】実施例11 (5R,6R,2’R)−8−オキソ−3−(2’−テ
トラヒドロフリル)−1−アザ−4−チアビシクロ
[3.3.0]オクト−2−エン−2,6−ジカルボン
酸ナトリウム(23)の合成:
Example 11 (5R, 6R, 2'R) -8-oxo-3- (2'-tetrahydrofuryl) -1-aza-4-thiabicyclo [3.3.0] oct-2-ene- Synthesis of sodium 2,6-dicarboxylate (23):

【28】 (5R,6R,2’R)−6−アリルオキシカルボニル
メチル−2−(2’−テトラヒドロフリル)ペネム−カ
ルボン酸アリルエステル(10) 100mg(0.2
6mmol)の酢酸エチル:塩化メチレン(3:1)溶
液(2ml)に、2−エチルヘキサン酸 ナトリウム塩
(92mg)、トリフェニルフォスフィン(6.4m
g)、テトラキストリフェニルフォスフィンパラジウム
(6.4mg)を順次加え、室温で20分間撹拌した。
溶媒を留去後、アセトニトリル:水(3:1) 1.2
mlに溶解し、不溶物を瀘別してそのままHPLCで精
製し標記化合物(23)を含むフラクション 97mg
を得た。
[28] (5R, 6R, 2'R) -6-allyloxycarbonylmethyl-2- (2'-tetrahydrofuryl) penem-carboxylic acid allyl ester (10) 100 mg (0.2
6 mmol) in ethyl acetate: methylene chloride (3: 1) solution (2 ml), 2-ethylhexanoic acid sodium salt (92 mg), triphenylphosphine (6.4 m).
g) and tetrakistriphenylphosphine palladium (6.4 mg) were sequentially added, and the mixture was stirred at room temperature for 20 minutes.
After distilling off the solvent, acetonitrile: water (3: 1) 1.2
97 ml of a fraction containing the title compound (23), which was dissolved in ml, filtered to remove insoluble matter, and purified directly by HPLC.
Got

【0051】IR(film,cm−1):3456,
1690,1596,1397 NMR(CDCl/TMS,δppm):1.90−
2.20(m,2H),2.10−2.20(m,1
H),2.87(dd,1H,J=16Hz,9H
z),2.98(dd,1H,J=18Hz,10H
z),3.70−4.00(m,3H),5.32
(t,1H,J=6Hz),6.03(d,1H,J=
7Hz)
IR (film, cm -1 ): 3456,
1690, 1596, 1397 NMR (CDCl 3 / TMS, δppm): 1.90-
2.20 (m, 2H), 2.10-2.20 (m, 1
H), 2.87 (dd, 1H, J = 16Hz, 9H
z), 2.98 (dd, 1H, J = 18Hz, 10H
z), 3.70-4.00 (m, 3H), 5.32.
(T, 1H, J = 6 Hz), 6.03 (d, 1H, J =
7Hz)

【0052】実施例12 (5R,6S,2’R)−8−オキソ−3−(2’−テ
トラヒドロフリル)−1−アザ−4−チアビシクロ
[3.3.0]オクト−2−エン−2,6−ジカルボン
酸ナトリウム(24)の合成:
Example 12 (5R, 6S, 2'R) -8-oxo-3- (2'-tetrahydrofuryl) -1-aza-4-thiabicyclo [3.3.0] oct-2-ene- Synthesis of sodium 2,6-dicarboxylate (24):

【29】 (5R,6S,2’R)−6−アリルオキシカルボニル
メチル−2−(2’−テトラヒドロフリル)ペネム−カ
ルボン酸アリルエステル(11) 89mg(0.23
mmol)を用いて実施例11と同様の反応により、標
記化合物(24)を含むフラクション 96mgを得
た。
[29] (5R, 6S, 2'R) -6-allyloxycarbonylmethyl-2- (2'-tetrahydrofuryl) penem-carboxylic acid allyl ester (11) 89 mg (0.23
was used in the same reaction as in Example 11 to obtain 96 mg of a fraction containing the title compound (24).

【0053】IR(film,cm−1):1718,
1581,1196 NMR(CDCl/TMS,δppm):1.90−
2.20(m,2H),2.40−2.60(m,1
H),3.00(d,1H,J=2Hz),3.03
(d,1H,J=4Hz),5.44(t,1H,J=
7Hz),6.24(d,1H,J=7Hz)
IR (film, cm -1 ): 1718,
1581, 1196 NMR (CDCl 3 / TMS, δppm): 1.90-
2.20 (m, 2H), 2.40-2.60 (m, 1
H), 3.00 (d, 1H, J = 2Hz), 3.03
(D, 1H, J = 4 Hz), 5.44 (t, 1H, J =
7Hz), 6.24 (d, 1H, J = 7Hz)

【0054】[0054]

【発明の効果】本発明によれば、優れた抗菌活性が期待
されるγ−ラクタム誘導体やその中間体として有用なγ
−ラクタム誘導体が極めて簡便容易に製造しうる。
INDUSTRIAL APPLICABILITY According to the present invention, γ-lactam derivative which is expected to have excellent antibacterial activity and γ which is useful as an intermediate thereof
-Lactam derivatives can be produced very simply and easily.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 式(I): 【化1】 (式中、R及びRは、同一または異なるカルボン酸
の保護基を示し、点線は結合の存在または不存在を示
し、結合が存在しない場合には、R及びRはメチル
基を示し、結合が存在する場合には、Rはテトラヒド
ロフリル基またはテトラヒドロフリルメチル基を示し、
は存在しない)で表されるβ−ラクタム誘導体にお
いて、Rで示されるカルボン酸の保護基を除去するこ
とを特徴とする式(II): 【化2】 (式中、R、R、R及び点線は前記した意味を有
する)で表されるγ−ラクタム誘導体の製造法。
1. Formula (I): (In the formula, R 1 and R 2 represent the same or different carboxylic acid protecting groups, the dotted line indicates the presence or absence of a bond, and when the bond does not exist, R 3 and R 4 represent a methyl group. And when a bond is present, R 3 represents a tetrahydrofuryl group or a tetrahydrofurylmethyl group,
R 4 does not exist) in the β-lactam derivative represented by the formula (II), wherein the protecting group for the carboxylic acid represented by R 1 is removed: (In the formula, R 2 , R 3 , R 4 and the dotted lines have the above-mentioned meanings) A method for producing a γ-lactam derivative.
【請求項2】 Rで示されるカルボン酸の保護基が
アリル基、トリクロロエチル基またはメチル基であり、
及びRで示されるカルボン酸の保護基がベンジル基、
アリル基またはトリクロロエチル基である請求項1記載
の製造法。
2. The protecting group for carboxylic acid represented by R 1 is allyl group, trichloroethyl group or methyl group,
And a carboxylic acid protecting group represented by R 2 is a benzyl group,
The production method according to claim 1, which is an allyl group or a trichloroethyl group.
JP5195066A 1993-06-24 1993-06-24 Production of gamma-lactam derivative Pending JPH0710883A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5195066A JPH0710883A (en) 1993-06-24 1993-06-24 Production of gamma-lactam derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5195066A JPH0710883A (en) 1993-06-24 1993-06-24 Production of gamma-lactam derivative

Publications (1)

Publication Number Publication Date
JPH0710883A true JPH0710883A (en) 1995-01-13

Family

ID=16334993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5195066A Pending JPH0710883A (en) 1993-06-24 1993-06-24 Production of gamma-lactam derivative

Country Status (1)

Country Link
JP (1) JPH0710883A (en)

Similar Documents

Publication Publication Date Title
JP3330972B2 (en) Diastereoselective synthesis of nucleosides
US4631150A (en) Process for the preparation of penems
CA1234099A (en) Process for the production of penems
US4155912A (en) 2-Methylpenem-3-carboxylic acid antibiotics
KR900001170B1 (en) A preparation process for 4-acetoxy-3-hydroxyl ethyl-azetizin-2-one derivatives
FI86852C (en) New compounds and processes for their preparation
HU187807B (en) Process for producing optically active penemes
NO167291B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PENEM RELATIONS.
IE47037B1 (en) Isopenicillins, processes for their preparation, and compositions containing them
JPH02131487A (en) Manufacture of 2-thiacephem derivative
JPH0710883A (en) Production of gamma-lactam derivative
EP0088488B1 (en) Antibacterial agents, their preparation and use
KR910005230B1 (en) Process for producing azetidinones
JPH0247996B2 (en)
JPS62164689A (en) Novel beta-lactam compound and production thereof
IT9009393A1 (en) PENEM DITIOCARBAMMATI, THEIR USE AND RELATED MANUFACTURING PROCEDURE
JP3059475B2 (en) Method for producing 2-azetidinone derivative
US4169833A (en) Novel phosphorane intermediates for use in preparing penem antibiotics
FI70717C (en) 2-AZETIDINONDERIVAT FOER ANVAENDNING SOM MELLANPRODUKTER VID FRAMSTAELLNING AV THERAPEUTISKT ANVAENDBARA PENEMDERIVAT
EP0574784B1 (en) Process for preparing (1&#39;R,3S,4R)4-acylthio azetidinones
JPH0656836A (en) Production of carbapenem derivative
JPH0247995B2 (en)
KR930001405B1 (en) Process for preparing 2-(4-substituted amino-3-oxo-isoxazolydin-5-oxo)-tetra hydrofuran carboxyl acid derivatives
JPH08253483A (en) Bicyclic heterocyclic compound
IE59260B1 (en) Process for 2-( 1-oxo-3-thiolanyl)-2-penem antibiotics